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~,bstraet Zinc-finger proteins are involved in several cellular 
processes. Some of these proteins are implicated in the primary 
cellular response in regenerating liver and mitogen-stimulated 
cells. Using a rat cDNA brain library, we have isolated a clone 
designated NOR-2, encoding a protein containing two zinc-finger 
motifs and whose expression is highly induced during G0/GI 
transition. We analysed the expression of NOR-2 mRNAs during 
early growth in regenerating liver and in both insulin-stimulated 
H4-11 cells and pheochromocytoma-derived cell line PCI2 
treated by NGF. In these systems, there is an early, rapid and 
transient accumulation of NOR-2 mRNAs. The induction of 
NOR-2 mRNAs does not require de novo protein synthesis, since 
it is not prevented by cycloheximide treatment. Mobility shift 
assays show that NOR-2 protein binds to NBRE, a target se- 
quence for r-NGFI-B family. Structurally, NOR-2 is closely re- 
lated to the recently identified NOR-I factor. Therefore, like 
NOR-I, NOR-2 belongs to the r-NGFI-B sub-family of nuclear 
receptors superfamily. 
Key words: Immediate-early gene; Zinc-finger protein; 
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I. Introduction 
The transition from quiescence into the G1 phase of the cell 
cycle is regulated through the input of extracellular signals. 
Indeed, multiple factors including circulating hormones, 
growth factors and nervous input, participate in the regulation 
of the primary cellular response. This response characterises, 
at least in part, the initiation of the GO to G1 transition of the 
cell cycle. It also results in a transcriptional ctivation of the 
group of immediate-early esponse genes [1]. Basically, a tran- 
sient and rapid activation of these genes occurs within the first 
few hours of cell activation and does not require de novo 
protein synthesis. Several immediate-early genes encoding se- 
cretory proteins, structural proteins uch as actin and transcrip- 
tion factors such as Jun [2], Fos [3] and zinc-finger proteins [4] 
are probably involved in the regulation of expression of genes 
at the later point of the cell cycle (called delayed genes). As 
such, they may have a crucial role in the cell cycle progression 
and cell growth. 
Several models of mitogen-stimulated cells have been used 
to study various aspects of the cell growth. However, liver 
regeneration provides one of the few models for analysis of cell 
growth in vivo. Indeed, partial hepatectomy s nchronizes the 
majority of hepatocytes during the proliferating phase of the 
first mitosis. This model has also been used to analyse the 
expression of hepatic genes during different phases of the cell 
cycle. It has been shown that transferrin mRNA is detectable 
very late in the regenerating liver, and thus it belongs to the set 
of delayed genes of the cell cycle [5]. The transferrin gene is 
therefore probably regulated in part by immediate-early genes. 
Earlier studies allowed us to identify the 5' regulatory regions 
involved in the expression of the transferrin gene in different 
tissues uch as liver, brain and testis. Furthermore it was possi- 
ble to characterize the specific combination of transcription 
factors which interact with these regions [6,7]. Such results 
emphasize the requirement for different combinations of tran- 
scription factors in different issues to achieve specific expres- 
sion. Amongst hese factors the immediate-early gene are prob- 
ably involved. 
To further understand the regulation of the transferrin gene 
it was necessary to identify additional factors, unknown until 
now, involved in the tissue specific expression. To this end, we 
screened an adult rat brain cDNA library with a probe encod- 
ing the DNA binding domain of COUP-TF [8], a member of 
the nuclear eceptor superfamilly. This screening resulted in the 
identification of a cDNA clone designated as NOR-2 (neuron- 
derived orphan receptor), since the structural analysis hows 
that it is similar to the members of the r-NGFI-B family [9], and 
particulary very closely related to the recently identified NOR- 1 
factor [10]. All of these factors belong to the nuclear eceptor 
superfamily. 
In this paper, we report the structure and characterization 
of NOR-2, a novel immediate-early gene. We show that NOR-2 
mRNAs are highly and rapidly induced in the liver systems: 
both liver regeneration after partial hepatectomy and insulin- 
stimulated H4-II cells. 
2. Materials and methods 
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2.1. cDNA library screening 
An adult rat brain ~ZappIl cDNA library was screened with a ran- 
dom labelled probe (megaprime kit, Amersham) encoding the DNA 
binding domain of COUP-TF. One partial cDNA clone was isolated 
and used for subsequent screening under high stringency (final wash: 
0.1 SSPE, 0.1% SDS, 65°C for 20 min) to obtain full-length cDNA. 
Nucleotide sequencing of both strands was done by the dideoxy chain 
termination method using the T7 sequencing kit (Pharmacia Biotech). 
2.2. Cells culture and treatment conditions 
H4-II cells were grown in COON's F-12 modified medium (Seromed) 
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supplemented with 5% fetal calf serum (Gibco-BRL). PC12 cells were 
grown in Dulbecco's modified Eagle medium (Gibco-BRL) containing 
10% horse serum (Boehringer Mannheim) and 5% fetal calf serum. 
To produce quiescence, the medium was changed to serum free me- 
dium for 48 h. Following serum privation, H4-II cells were treated with 
insulin (10 -8 M, Sigma) and cycloheximide (10 c/g/c/l, Sigma). PC 12 cells 
were treated with NGF (50 ng/ml, Sigma). 
2.3. Regenerating fiver aider partial hepatectomy 
Male Wistar ats (2 months old, 15(L220 g) were anesthesized with 
ether and subjected to 70% partial hepatectomy [11]. Animals were 
allowed to recover for different times prior to decapitation a d isolation 
of the remaining liver lobes. 
2.4. RNA preparation and analyses 
Poly (A) + RNA were prepared according to the Dynabeads kit 
(Dynal) from cells or tissues (brain and liver). Northern blots analyses 
were performed with 1.5 c/g of Poly (A) ÷ RNA after separated by 
electrophoresis on a 1% agarose, 0.6% formaldehyde, MOPS denatur- 
ing gel and capillary transfer on hybond N + membranes (Amersham). 
The NOR-2 probe corresponds to the NruI BssHII fragment, which 
included nucleotides 765-1051. Standard hybridization and wash con- 
ditions were used according to the manufacturer. The amount of RNA 
was normalized by hybridization with the GAPDH probe (data not 
shown). 
2.5. In vitro transcription~translation 
In vitro transcription/translation of NOR-2 was performed with the 
TNT T7 coupled reticulocyte system (Promega, Madison, WI, USA). 
The experiment was carried out either in the presence of[35S]methionine 
and run on a 12.5% (SDS)-polyacrylamide gel or cold methionine for 
use in mobility shift assay. We obtained a major band at about 48 kDa 
corresponding to a protein translated from the predicted initiation 
codon (487 nucleotides) (data not shown). 
2.6. Mobility shift assay 
The conditions of mobility shift assay was adapted from [12]. The 
binding reactions were performed with 5/21 of reticulocyte lysate. After 
20 min of incubation at room temperature, the samples were loaded on 
a 6% acrylamide gel. For the competition experiments, 100 ng of cold 
oligonucleotide w re added to the binding reactions. 
The sequences of synthetic oligonucleotides used are: 
NBRE: 5' GAGTTTTAAAAGGTCATGCTCAATTT 3' 
non-specific oligonucleotide from the melanotransferrin gene [13]: 
5' CAGCGTCACGTGGAGTTTTGCCAAAGGA 3' 
3. Results 
3.1. Isolation and sequence of NOR-2 cDNA 
The complete cDNA encoding NOR-2 was isolated from an 
adult rat brain AZAPII cDNA library. The library was screened 
with a 32p-labeled cDNA probe corresponding to the DNA 
binding domain of COUP-TF. One partial cDNA clone was 
isolated and used for subsequent screening to obtain full-length 
cDNA. This last cDNA was designated as NOR-2. The size of 
the cDNA insert is 4,275 nucleotides (nt) and contains a major 
open reading frame of 1,290 nt starting with an initiation 
methionine at 487 nt. Nevertheless, the ATG codon at this 
position had a poor flanking sequence for translation i itiation 
according to the Kozak consensus sequence. The 5' untrans- 
lated region of the NOR-2 cDNA contains everal stop codons 
indicating that the whole coding region has been cloned. The 
open reading frame is followed by a 3' untranslated region in 
which the ATTTA motif was found seven times. This element 
is known to confer mRNA instability, a property of many 
immediate-early genes [14]. No canonical AATAAAA has been 
found, instead an ATTAAA motif was localized 40 nucleotides 
before the poly(A) tail [15] (Fig. l). However, we cannot rule 
out the possibility that the NOR-2 cDNA lacked a poly (A) tail. 
3.2. Structural characteristics of NOR-2 cDNA and homology 
to the r-NGFI-B family 
The first analysis of the predicted NOR-2 protein sequence 
revealed that this factor exhibits imiliarities in sequence and 
structure to the nuclear eceptor superfamily. Indeed, NOR-2 
contains two zinc-fingers of the C2C2 type, as do of the mem- 
bers of this family [16]. While we finished the sequencing of 
NOR-2, a second computer analysis howed that this factor 
was identical, from ATG (at 487 nt) until 1,746 nt, to NOR-1 
which has been very recently identified [10]. In NOR-2 the stop 
codon was found at 1,777 nt, (i.e. 31 nt from 1,746 nt) whereas 
the stop codon in NOR-1 was found 627nt from the divergent 
point between these two proteins. Furthermore, NOR-2 and 
NOR-1 differ completely in both 5' and 3' non coding regions 
(Fig. 2A). 
It is therefore indisputable that NOR-2 is very closely related 
to NOR-1. Like NOR-l, NOR-2 belongs specifically to the 
r-NGF1-B [9] family showing in particular high homology with 
both r-NGFI-B and r-RNR-I [17] factors in the DNA binding 
domain (91% and 97% respectively). More precisely, in the P 
and A box regions, NOR-2 shows 100% homology to the 
NGFI-B and RNR-1. These two regions have been identified 
as crucial in DNA recognition. It has been shown that the A 
box is required for recognition of the two adenine-thymidine 
bases pairs at the 5' end of the NGFI-B response lement 
(NBRE) [18,19]. Concerning the D box, which is involved in the 
orientation of dimeric receptors [20], NOR-2 again shows high 
homology with the other three members of the sub-family (Fig. 
2B). In contrast, NOR-2 does not contain the carboxy-terminal 
region, which corresponds tothe ligand binding domain. NOR- 
2, as well as NOR-l, shows a high variability in the N-terminal 
region compared to the other three related proteins. Several 
studies concerning the other factors of this family, indicated 
that the N-terminal region is involved in the transactivation 
activity [21,22]. 
3.3. Induction of NOR-2 in liver proli~brating cells and in PC 12 
cells stimulated by NGF 
In order to analyse the induction of NOR-2 expression dur- 
ing G0/G1 transition of the cell cycle we used three different 
models: an in vivo model consisting of liver regeneration after 
partial hepatectomy, and both insulin stimulated H4-II 
hepatoma cell line and pheochromocytoma-derived cell line 
PC12 treated by NGF, as in vitro systems. Northern blot anal- 
ysis revealed the presence of several mRNAs species corre- 
sponding to NOR-2 in all types of cells and tissues that have 
been studied. NOR-2 mRNAs (6 kb, 5.6 kb, 2.9 kb, 2.4 kb) were 
only barely detectable in adult liver tissue and were rapidly 
induced in regenerating liver, after only 15 rain. They reached 
a maximum level 30 min after partial hepatectomy. Thereafter 
the mRNAs decreased and reached resting levels 16 h after 
hepatectomy (Fig. 3A). NOR-2 mRNAs were barely detectable 
at all time points following sham surgery (data not shown). 
The same species of NOR-2 mRNAs detected in regenerating 
liver, were also expressed at a high levels in insulin-treated 
H4-II cells 3 hours after stimulation (Fig. 3B). Superinduction 
of NOR-2 mRNAs in the presence of cycloheximide (CHX) 
indicated that NOR-2 gene does not require de novo protein 
synthesis and thus defined NOR-2 as an immediate-early gene. 
NOR-2 mRNAs are induced to a lesser extent in NGF-treated 
PC12 cells (Fig. 3C). It should be noted that all these experi- 
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1 CA•A•GTTTACAAATCAACCTATGTATATCTTGGGGGATCAATGG•CTCCTCTCCAAATTAATTAACAAGTTATTTCCTTCCTTTCCCCTTGGCCTT 
98 CCCTATGGCTAAGGAGACAACTCCAATTGTTTTTGGGAGAGTGTCGTCGTTGTTGTTGCTGTTGTTGTTGTTGTTTAGGAGTTAAACTAATTTAAAA 
[95 ATGGGCTTATGAGAGAAAGACTCTATATCAAAGTTTAATGAACAGAGCAAGGGAGAGAAGATGGGTGTAGCCACCCCAGGGAGTCCATTTTATTGCC 
~92 GGTGGGGCCCCTTTGTCAGTCAGGGTCTCAGCTGTCTTCTCAGGGAGGAAGAAAGGAGGCTAGGGGCATTACGCCTTCG•CAGCAGGTGGGAGAGGA 
389 TGCCACTCTGTTTCCTGATTCTGGAGAGCAGTGGATCCACTGTGGTGACCGATGGAGTGTCAACTGGCTTCTGAGCCCCTTTCTCTGTCCCTGTAGA 
~86 TATGCCCTGCGTGCAAGCCCAATATAGCCCTTCGCCTCAGGGGTCCACTTATCCCACGCAGACTTATGGCTCGGAATACACCACAGAAATCATGAAC 
583 CCCGACTATGCCAAGCTGACCATGGACCTCGGTAGCACGGGGATCATGGCCACGGCCACGACGTCCCTGCCCAGCTTCAGTACCTTCATGGAGGGCT 
680 ACCCCAGCAGCTGCGAACTCAAGCCCTCCTGCCTGTACCAAATGCCGCCTTCTGGGCCTCGGCCTTTGATCAAGATGGAAGAGGGTCGCGAGCATGG 
777 CTACCACCACCACCACCACCATCACCATCATCATCACCACCACCACCAGCAGCAGCAGCCGTCCATTCCTCCTCCCTCTGGCCCCGAGGACGAGGTA 
874 CTGCCCAGCACCTCCATGTACTTCAAGCAGTCTCCGCCGTCTACGCCGACCACTCCAGGCTTCCCCCCGCAGGCGGGGGCGCTGTGGGACGACGAGC 
971 TGCCCTCTGCGCCTGGCTGCATCGCTCCGGGACCGCTGCTGGACCCGCAGATGAAGGCAGTGCCCCCAATGGCCGCTGCTGCGCGCTTCCCGATCTT 
068 CTTCAAGCCCTCACCGCCACACCCTCCCGCGCCCAGCCCAGCCGGCGGCCACCACCTGGGCTATGACCCCACGGCCGCAGCTGCGCTCAGTCTACCC 
165 CTGGGAGCCGCGGCCGCCGCGGGCAGCCAAGCTGCTGCGCTCGAGGGCCATCCGTACGGGCTCCCGCTGGCCAAGAGGACGGCCACGTTGACCTTCC 
262 CTCCGCTGGGCCTCACAGCGTCCCCTACCGCGTCCAGCCTGCTGGGAGAGAGCCCCAGCCTACCATCGCCACCCAATAGGAGCTCATCATCCGGCGA 
359 GGGCACGTGTGCTGTGTGCGGGGACAATGCTGCCTGCCA•CACTACG•AGTCC•CACCTGCGAGGGCTGCAAGGGCTTCTTCAAGAGAACGGTGCAG 
456 AAAAACGCAAAATATGTTTGCTTGGCAAATAAAAACTGCCC•GTA•ACAAGA•AC•TC•AAATCGATGTCAGTACTGCAGGTTTCAGAAGTGTCTCA 
553 GTGTCGGGATGGTGAAGGAAGTTGTGCGTACAGATA•TCTGAAA•••A•GAGA•GTCGTCTGCCTTCCAAACCAAAGAGCCCACTACAACAGGAGCC 
650 CTCGCAGCCCTCCCCACCATCTCCTCCGATCTGTATGATGAAC•CCCTT•TCCGAGCTTTAACAGACGCAACGCCCAGAGACCTTGATTACTCCAGA 
747 GTAAGTTCCGTGAACCGTTTCGAATGGTTCTGATTTTCCATTCAT•ATCGTCGTAC•AAGGGTTGGCTGAATGACTGCGCCCGGCTCTGTGCTAGTC 
844 CTACTACTAGTTTTTTTTACCTTTCCTATAGTTCTCATTTCATTTAGCAAAAAGTCCATTCACTCTACCAAATAATTTTTGCTTTATTGGATCTCTG 
941 AGTGGCTTTAATAAATGACGCCTGACAGGGCTACACCTGCCACCCCTAT•GTGGCAGGATTCTCTGTGGTGCCAATGAAAAGCCCCACAGGTGAACT 
038 GCAATTTGTAGGGTTCCTCTTCTTCTTCTTTTGTTTTGATGCCTTAGACATTGTGGAGTATTGGATTTCTTACATTGTGAGTAGACTCTGTTGCTGA 
135 GCCCCCAAGTTAACCTGAAGTAGTCTACCCGGTTGCATCCTCGCTGATTAACTTGCTGCTTGTATGGGGGTGGGGTGGAGGTCAGACTCTGAGGAGG 
232 AAGAAGCCCTGGGCTTGGTGTCAGAGGCATCAGGAGGACTGGGATG•AGCACTACAGTTTCTGTTCCCTGCCTATGTTACCTGGCTCCTCTTCTTGG 
329 CTCTGTCTCCCTGCAGTGGAAATCATTACAATATTTAACACCAGAGGAGGGGTTTTGAGCATCAGTCACACAAGGATGACAAAAACCGTGTTTTTAA 
426 AAAAACGTAAACGATTACCAATGTTGTTATCTCAGTCAACCAAAACATATCAACATTTCAGTTTCACATAGGACATCATAAAAAAAAAAATAATCGC 
523 CAGTCTGAAGTCTATTAACTGC•CTAAATCTGAATGCTATTGA•AAGGGTGATCAAAGGTTTTTGAGAAAACGTACAAACATTATGATGAGCCCATG 
620 TCTTATTGAATTTTGAAAAGCGGAGCTCTAGTAAAATACAGTCTTATTACAAATGAAAGAGGAGAAAAAAATGATCCTAGTTACTGAATAATTCTTC 
717 CCTGTTAAACATTGTGTCACACTGTCTCACTGCACCCTTGAAAGGGCCTGCGCT•CTCTAAGGGCCACCTACTTCACTTAGGAACACAAAGGAAGAG 
814 AGGCTGGTGTGGGGTCTCCACTGGTTGATCTGATTTCCTTCCCAT•GCTAATTCAGCATTTCGGCATCTGGGTGAATGCCTGCAAAAAGACAGGAGT 
911 GTGCCTTTGCTACTGGGCCCTCCTCCTGGGGTTGTAGTGTTGACAAAAATGCTGAGTGTGCCCGCTGAGATCCTCTTGCCCCTCCTCCCTGCCTTCG 
008 TTCTAGGCCCTCCCTACACCTGATCACAAGACCCCTTGTGAGTAGCTTGGTAGATCCTTAGCACCAAAGGTTGAGGACTCTTACTCTGATTGTAAGT 
105 ACCATCTCTTGATGAAAAGTCGGTCTCAAACAGCCTAACAGAGTAGTTCACCGACTAAGG•TTCAGGCTCTGAAAGCAGGCAAGTCTAGATAAAAAT 
202 CCTAATGCCAGCATTTACCAGCTGGGTGACCTTGAGAAACTGATATGTTCAGT•CCTGGATTTCTTCATCTTTGTTATTAGATGATATTACCTGCTT 
299 CCTGGGATTCTTTGTGAAGATTAAATAGGATGGCATTT•TCAAAACTTCAGCATGGGACCCA•TATATTGTTTCCTTGATCAAACCCTTCACTCTGG 
396 GCATATATCCAATGTGCTAATAAGTATAGGCACCACACAGTGAG•TACC•TGTAGCAACGCCATTAATATAAGTATTATGATTCCTATGGCCCAATA 
493 AGAAAATCAAAACAGAGAGAGGTGAAAGAACTGAGTA•CCCAA•GTCACACATAAAACGACTATCAGAGGTCAAATTAGGAGTCAGGGTTCACTGAC 
590 TCTCTGGTTGCAGTGAGGGTGGGAGACACAAGGGTTTGGGGCAT•AAGATTCTCCTCCCCCAAAGCACCCCCACCTCTCCCTCTGCACTTCATCTGC 
687 AGTAATGAAACCATAGTAACTGCCTTGGCTAAGATCACAGCACACAATCTGCGATCATCCCGGAGTATTTGGCATTACTTCTGATGGTCAGTCAAGA 
784 AAAGTTGCTCCCCCCAAAATGATATTGTGTCCCCAAACTATCTAAATTGTCAGTGTCTAT•GCCTAATTTTCATGCGGCAGAATGTCTCCCCTAGTA 
881 TGTTGAGTTGTCCCAGCTGGGAAATGTCTCTACATTGAAAAAAATCCAATCCAGTGTGTTTGCTTGTCTCTGCACCATTCAGTCTGTTAGTCTGGAG 
978 TCATCACCCTCATCAACAAACATTTATCCAATTTAATT•TTAGCTTT•CCCCAAATAGCA•ATTGCCCATGCCAGAGTCTGGGTCGTGCTGATGCTA 
075 CCTTCGAGGCCTAGCTCAATTTTGCAAAGCATATTTATTTCAGTT•CATT•TTTTGGAATCAGGTTGAACTTCGTTCGCTTGGGTTCTCCTGCATTT 
172 ~GATAGCTCTACAAAATTATCAAAAATTGGACCCAAATCAACTAAA~TAAAAAGACTTTTAAAAAAAATACAGCAAGCTTTCATCAAAAAAAAAAAA 
269 AAAAAAA 
Fig. 1. Nucleotide sequence of NOR-2. The ATG flanked by the Kozak consensus sequence and TGA are underlined. In the 3' untranslated region, 
the seven ATTTA motifs are indicated in italic and underlined. The motif ATTAAA which could be a polyadenylation signal is also indicated. 
ments were carried out using polyadenylated RNAs, indicating 
that NOR-2 is expressed at very low levels. Its expression anal- 
ysis in adult tissues (heart, spleen, lung, liver, skeletal muscle, 
kidney, testis) from polyadenylated RNAs, shows a weak basal 
expression (data not shown). In contrast, in the brain both 6Kb 
and 5.6 kb transcripts are more abundant (Fig. 3D). 
3.4. In vitro translation and characterization ~?[ DNA binding 
elements of NOR-2 
In vitro translated NOR-2 protein was used to test the bind- 
ing of the NOR-2 to an NGFI-B response lement (NBRE) 
[18-19]. This motif has been identified as an r-NGFI-B/m- 
Nur77 and r-RNR-l/m-Nurrl  response lement. The predicted 
molecular mass of 47 kDa of NOR-2 was confirmed by SDS- 
polyacrylamide g l electrophoresis u ing the translated in vitro 
protein (data not shown). Reticulocyte lysate has endogenous 
binding activity to the NBRE oligonucleotide. It is however 
possible to separate this activity from the specific binding activ- 
ity of NOR-2 (Fig. 4). The mobility shift assay shows that 
NOR-2 binds specifically to NBRE response lement. Excess 
of unlabeled oligonucleotide (100-fold) reduced significantly 
this binding and no competition was observed when a non 
specific oligonucleotide was used (Fig. 4, lane 2 and lane 4). 
Thus, as expected, NOR-2 binds to the NBRE motif, like the 
other three members of the r-NGFI-B family. 
4. Discussion 
We have identified NOR-2, a novel member of the orphan 
steroid receptor superfamily. We demonstrated that the NOR-2 
276 
A 
NOR-2 
5' untranslated r gion 
486 nt 
NOR-1 
5' untranslated region 
699 nt 
DNA BINDING DOMAIN (2 C2C2)_ 
ro l l  
Z Petropoulos et al./FEBS Letters 372 (1995) 273-278 
EGCKG LANKN RRGRLPS [iiiil] 
P Box D Box 
coding region 
1290 nt 
A Box 
DNA BINDING DOMAIN (2 C2C2)~ 
v 
EGCKG LANKN RRGRLPS 
P Box D Box 
coding region 
1884 nt 
A Box 
COMMON REGION 
// 
3' untranslated region 
2495 nt 
3' untranslated region 
1814 nt 
B 
NGFI-B EGCKG LANKD RRGRLPS 
RNR-1 EGCKG LANKN RRGRLPS 
P Box D Box A Box 
Fig. 2. (A) Schematic representation f full-length NOR-2 cDNA. Comparison with NOR-1 cDNA. The boxes and represent the divergent 
sequence between the coding region of the two cDNA. (B) Comparison between the P, D and A boxes of NOR-2 and NOR-1 with that of NGFI-B 
and Nurrl. 
mRNAs are rapidly and highly induced in liver regeneration 
following partial hepatectomy, aswell as in both insulin-stimu- 
lated H4-II hepatoma cell line and pheochromocytoma-derived 
cell line PC12 treated by NGF. This early and transient NOR-2 
mRNAs expression occurs during the GO to G1 transition when 
the cells re-enter the cell cycle. Furthermore, the fact that this 
expression was increased in the presence of cycloheximide indi- 
cated that the NOR-2 gene does not require de novo protein 
synthesis. All of these characteristics allowed us to define 
NOR-2 as an immediate-early gene. 
NOR-2 shows some similarities in its expression to the r- 
NGFI-B and RNR- 1 factors, both members of the 2-NGFI-B 
family. These genes are also induced during G0/G1 transtion, 
as the immediate-early genes. We show that like r-NGFI-B, 
NOR-2 was induced in PC12 cells treated by NGF and like 
RNR-1, NOR-2 was increased in the liver regenerating model. 
Despite these similarities, NOR-2 expression shows a notable 
difference with r-NGFI-B and RNR-1. For instance, unlike 
RNR-1 and r-NGFI-B, NOR-2 was accumulated athigh level 
in insulin-stimulated H4 II hepatoma cell line. Furthermore, 
the pattern of NOR-2 expression shows the presence of several 
species of mRNAs (6 kb, 5.3 kb, 2.9 kb, 2.4 kb), whereas, with 
r-NGFI-B and RNR-1, only one messenger is detected. More- 
over, apart from the brain, where a low accumulation of 6kb 
and 5.6 kb NOR-2 mRNAs was observed, its expression isvery 
marginal. In constrast, r-NGFI-B is highly expressed in lung, 
brain and adrenal tissues. As far as RNR-1 is concerned, high 
expression isdetected in the brain. Thus far, NOR-I,  which has 
been recently identified, is the most closely related to NOR-2. 
Analysis of NOR-1 mRNA shows that it is expressed at high 
levels in cultured apoptotic neuronal cells and fetal brain. In 
addition, like NOR-2, NOR-1 is expressed at low level in adult 
brain. 
The differences in tissue-specific expression pattern and also 
in the number of mRNAs species between NOR-2 and other 
members of the r-NGFI-B family, suggest hat while they be- 
long to the same family, they may accomplish different fonc- 
tions. 
Several hypotheses could be made to explain the presence of 
different species of the NOR-2 messengers. For instance, this 
gene could fonction with several optional promoters. The op- 
tional use of these promoters could result in the synthesis of 
different ypes of NOR-2 mRNAs with different 5' non-coding 
sequences. Genes with alternative use of promoters have been 
described and result in synthesis of transcripts with alternative 
5' exons. Such a phenomenon can result in the synthesis of 
different proteins as in the case of myosin light chain IF/3F [23] 
or of identical proteins as for aldolase A [24]. Secondly, alterna- 
tive splicing and/or alternative polyadenylation sites could be 
at the origin of the different NOR-2 mRNAs. 
The cDNA sequence analysis reveals that there is identity 
between the nucleotide sequences encoding the first 419 resi- 
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dues of NOR-2 and NOR-I .  Furthermore, both 5' and 3' non- 
coding regions of the NOR-2 and NOR-1 are completely differ- 
.~nt. If these differences are not due to a cloning artifact, the 
~ame hypotheses which explain the presence of several species 
,)f NOR-2 mRNAs, could be advanced. 
The analysis of the predicted NOR-2 protein sequence shows 
'.~he high degree of homology in the DNA-binding domains 
9etween NOR-2, NGFI-B, and RNR-1. It also shows that the 
DNA-binding domain of NOR-2 is identical to that of NOR-1. 
We demonstrated by mobility shift assays that the NOR-2 
protein binds specifically to NBRE, as predicted on the basis 
3f the sequence homology. This result indicates that all of these 
factors could bind to very similar sequences in target genes, 
suggesting that they may be regulate similar genes. However, 
these factors exhibit strong divergence in the N-terminal region, 
the putative transactivation domain. It is possible that these 
differences are the reflection of their implication at different 
times during the G0/G1 transition of the cell cycle. 
In conclusion, our results show that the NOR-2 expression 
in vitro and in vivo resemble the expression of immediate arly 
transcription factors such as Jun and Fos. These proteins are 
thought to play a role in activating transcription of delayed 
genes, involved in later phases of the cell cycle. Further ongoing 
studies are being undertaken to identify target genes whose 
expression is regulated by NOR-2. 
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Fig. 3. Northern blot analysis of NOR-2 gene induction i  regenerating 
liver, in various rat cell lines and in brain. (A) 0, Poly (A) ÷ RNA (1.5 
Bg) was analysed from quiescent, normal liver, Poly (A) ÷ RNA (1.5 ~g) 
was analysed from regenerating liver (15 rain, 30 min, 1 h and 16 h) after 
70% hepatectomie. (B) Poly (A) + RNA (1.5 #g) was analysed from 
H4-II treated with insulin (10-*M) and cycloheximide (10#g/ml) for 
various time, as indicated in the figure. (C) Poly (A) + RNA (1.5/tg) was 
analysed from PC 12 cells treated with NGF (50 ng/ml) for various time 
as indicated. (D) Poly (A) ÷ RNA (1.5 ¢tg) was analysed from adult rat 
brain. The northern blots were exposed for 10 days. 
competitor / ~'~ ¢,~' / 
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lysate 
NOR-2 - - -~  
free probe ~1~ 
1 2 3 4 
Fig. 4. NOR-2 binds specifically to the NGFI-B response lement. 
NOR-2 cDNA was transcripted/translated in vitro with TNT T7 cou- 
pled reticulocyte lysate and bound to radiolabeled NBRE, and run on 
a 6% native acrylamide gel. Lane 1, reticulocyte lysate programmed 
with NOR-2 cDNA. Lane 2, reticulocyte lysate as in lane 1 with 100X 
cold NBRE oligonucleotide. Lane 3, reticulocyte lysate as in lane 1 with 
100X cold non specific oligonucleotide (ns). Lane 4, unprogrammed 
reticulocyte lysate. 
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